Bladder Cancer Coverage from Every Angle

Syed A. Hussain, MD, on Neoadjuvant Treatment With Nintedanib for Locally Advanced Disease

Posted: Friday, October 30, 2020

Syed A. Hussain, MD, of the University of Sheffield, discusses the efficacy of nintedanib as a neoadjuvant treatment, its toxicity, whether it differs from standard therapy, and how it affects surgical outcomes.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.